The BLEOMYCINE Roger BELLON brand, founded in 1969 (France), from 2757 sister brands and 17477 competing brands. BLEOMYCINE Roger BELLON is owned by Sanofi, listed on the stock exchange of Paris The ISIN, the company's International Securities Identification Number, is FR0000120578. BLEOMYCINE Roger BELLON is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Sanofi
(BLEOMYCINE Roger BELLON)
over 5 years*
EUR 107.32